Corient Private Wealth LLC Reduces Holdings in Globe Life Inc. $GL

Corient Private Wealth LLC trimmed its stake in shares of Globe Life Inc. (NYSE:GL) by 35.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 171,286 shares of the company’s stock after selling 94,776 shares during the quarter. Corient Private Wealth LLC’s holdings in Globe Life were worth $24,170,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also bought and sold shares of the company. Hsbc Holdings PLC increased its stake in shares of Globe Life by 19.0% in the fourth quarter. Hsbc Holdings PLC now owns 129,997 shares of the company’s stock worth $18,225,000 after buying an additional 20,743 shares during the period. MidFirst Bank purchased a new stake in Globe Life during the 4th quarter valued at $529,000. Compound Planning Inc. grew its holdings in Globe Life by 4.3% in the 4th quarter. Compound Planning Inc. now owns 1,968 shares of the company’s stock worth $275,000 after acquiring an additional 82 shares during the last quarter. Invesco Ltd. grew its holdings in Globe Life by 2.7% in the 4th quarter. Invesco Ltd. now owns 3,948,676 shares of the company’s stock worth $552,262,000 after acquiring an additional 102,445 shares during the last quarter. Finally, Strive Financial Group LLC purchased a new position in shares of Globe Life in the fourth quarter valued at about $1,974,000. 81.61% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Globe Life

In related news, CEO James Matthew Darden sold 4,663 shares of Globe Life stock in a transaction dated Tuesday, April 28th. The shares were sold at an average price of $153.88, for a total transaction of $717,542.44. Following the completion of the transaction, the chief executive officer directly owned 58,451 shares of the company’s stock, valued at $8,994,439.88. This trade represents a 7.39% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CFO Thomas Peter Kalmbach sold 7,936 shares of the business’s stock in a transaction dated Friday, May 22nd. The stock was sold at an average price of $156.59, for a total transaction of $1,242,698.24. Following the sale, the chief financial officer directly owned 50,496 shares in the company, valued at $7,907,168.64. The trade was a 13.58% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 115,929 shares of company stock valued at $18,049,250 over the last 90 days. 2.11% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several brokerages have recently commented on GL. Truist Financial upped their price objective on shares of Globe Life from $180.00 to $185.00 and gave the company a “buy” rating in a research note on Friday, April 24th. Weiss Ratings raised Globe Life from a “buy (b-)” rating to a “buy (b)” rating in a research note on Wednesday, May 13th. Morgan Stanley boosted their price target on Globe Life from $176.00 to $181.00 and gave the company an “overweight” rating in a report on Thursday, May 21st. Keefe, Bruyette & Woods reaffirmed a “moderate buy” rating and set a $168.00 price target on shares of Globe Life in a research report on Thursday, March 26th. Finally, Texas Capital upgraded Globe Life to a “strong-buy” rating in a report on Wednesday, March 18th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, Globe Life presently has an average rating of “Moderate Buy” and an average target price of $174.11.

Globe Life Trading Up 0.8%

GL opened at $172.07 on Tuesday. The stock has a market cap of $13.36 billion, a PE ratio of 11.90 and a beta of 0.49. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.38. The business has a 50 day moving average of $155.99 and a 200-day moving average of $146.14. Globe Life Inc. has a 52 week low of $116.73 and a 52 week high of $175.63.

Globe Life (NYSE:GL) last issued its quarterly earnings results on Wednesday, April 22nd. The company reported $3.43 earnings per share for the quarter, missing the consensus estimate of $3.46 by ($0.03). The firm had revenue of $1.56 billion during the quarter, compared to analysts’ expectations of $1.56 billion. Globe Life had a return on equity of 20.94% and a net margin of 19.38%.Globe Life’s revenue for the quarter was up 5.3% on a year-over-year basis. During the same period in the previous year, the company earned $3.07 earnings per share. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. Equities research analysts predict that Globe Life Inc. will post 15.64 earnings per share for the current fiscal year.

Globe Life Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Monday, July 6th will be issued a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date is Monday, July 6th. Globe Life’s payout ratio is 9.13%.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.